iZafe Group (IZAFE-B) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
23 Apr, 2026Executive summary
Transitioned to a recurring revenue model, with Q4 2025 net sales of 2,435 TSEK, entirely from license revenues, marking a shift from prior hardware-driven sales.
Annual recurring revenue (ARR) at the start of 2026 is approximately 10 MSEK, in line with previous guidance.
Expanded Nordic presence with new distribution agreements in Iceland and Norway, and consolidated Dutch operations.
Launched new modular display and remote care system for Dosell post-quarter, enhancing product flexibility.
Financial highlights
Q4 2025 net sales: 2,435 TSEK (Q4 2024: 2,345 TSEK); full year 2025: 5,991 TSEK (2024: 7,954 TSEK).
EBIT for Q4 2025: -5,714 TSEK (Q4 2024: -5,697 TSEK); full year 2025: -16,783 TSEK (2024: -19,425 TSEK).
EBITDA for Q4 2025: -3,888 TSEK (Q4 2024: -4,714 TSEK); full year 2025: -12,018 TSEK (2024: -15,495 TSEK).
Net result for Q4 2025: -4,857 TSEK (Q4 2024: -5,908 TSEK); EPS: -0.01 SEK (Q4 2024: -0.02 SEK).
Cash flow from operations Q4 2025: -2,940 TSEK (Q4 2024: -178 TSEK); cash at period end: 1,673 TSEK.
Outlook and guidance
Entering 2026 with ARR of ~10 MSEK and a stable, scalable customer base.
Focus for 2026 is on expanding the customer base and increasing penetration within existing clients.
Strategic value seen in potential national procurement in Sweden, though not included in current forecasts.
Latest events from iZafe Group
- Recurring revenues and major contracts drive strong growth outlook, despite ongoing losses.IZAFE-B
Q1 202628 Apr 2026 - Recurring revenue model established, ARR at 10 MSEK, and Nordic expansion underway.IZAFE-B
Q3 202523 Apr 2026 - Recurring revenue model established, ARR quadrupled, and European expansion accelerates.IZAFE-B
Q3 20253 Nov 2025 - Recurring revenue growth and European expansion drive strong momentum in Q2 2025.IZAFE-B
Q2 202529 Aug 2025 - Revenue surged as Dosell expanded, with losses narrowing and growth momentum accelerating.IZAFE-B
Q3 202413 Jun 2025 - Net sales fell in Q2, but demand and new contracts signal growth ahead.IZAFE-B
Q2 202413 Jun 2025 - Recurring revenues and international expansion drive improved results and future growth.IZAFE-B
Q1 20256 Jun 2025 - Revenue doubled and ARR surged as iZafe accelerates international expansion.IZAFE-B
Q4 20245 Jun 2025